New Lung Cancer Drug Reduces Death Risk by 34%
3 stories
June 1
May 31
- STAT+: A standing ovation for RevMed, and caution for Akeso
statnews.com · May 31
- STAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer
statnews.com · May 31